Ausgabe 12/2017
Inhalt (23 Artikel)
The progress and current status of immunotherapy in acute myeloid leukemia
Dan Yang, Xiuqun Zhang, Xuezhong Zhang, Yanli Xu
The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia
Samah Nassereddine, Coen J. Lap, Faysal Haroun, Imad Tabbara
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)
Gabriele Nagel, D. Weber, E. Fromm, S. Erhardt, M. Lübbert, W. Fiedler, T. Kindler, J. Krauter, P. Brossart, A. Kündgen, H. R. Salih, J. Westermann, G. Wulf, B. Hertenstein, M. Wattad, K. Götze, D. Kraemer, T. Heinicke, M. Girschikofsky, H.G. Derigs, H. A. Horst, C. Rudolph, M. Heuser, G. Göhring, V. Teleanu, L. Bullinger, F. Thol, V. I. Gaidzik, P. Paschka, K. Döhner, A. Ganser, Hartmut Döhner, R. F. Schlenk
Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide
Jinxiao Hou, Shuye Wang, Yingmei Zhang, Dachuan Fan, Haitao Li, Yiju Yang, Fei Ge, Wenyi Hou, Jinyue Fu, Ping Wang, Hongli Zhao, Jiayue Sun, Kunpeng Yang, Jin Zhou, Xiaoxia Li
The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study
Cesar Homero Gutiérrez-Aguirre, Juan Antonio Flores-Jiménez, Julio Alatorre-Ricardo, Olga Graciela Cantú-Rodríguez, Adrián Rosas-Taraco, Rosario Salazar-Riojas, José Carlos Jaime-Pérez, Mónica Sánchez-Cárdenas, Leslie López-Silva, Azalia M. Martínez-Castilla, Mario Cesar Salinas-Carmona, David Gómez-Almaguer
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry
Brett L. Houston, Jennifer Jayakar, Richard A. Wells, Martha Lenis, Liying Zhang, Nancy Zhu, Heather A. Leitch, Thomas J. Nevill, Karen W. L. Yee, Brian Leber, Mitchell Sabloff, Eve St-Hilaire, Rajat Kumar, Michelle Geddes, April Shamy, John M. Storring, Mary-Margaret Keating, Mohamed Elemary, Robert Delage, Alex Mamedov, Rena Buckstein
Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis
Nan Yang, Jinqiu Chen, Hui Zhang, Zhiming Dai, Huan Yao, Xiaorong Ma, Ju Bai, Yilin Zhang, Wanggang Zhang
Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura
Gürkan Bal, Depré Fabian, Dzamashvili Maia, Frauke Ringel, Abdulgabar Salama
Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma
Yutaka Tsutsumi, Chie Nakayama, Koki Kamada, Ryo Kikuchi, Daiki Kudo, Shinichi Ito, Satomi Matsuoka, Souichi Shiratori, Yoshiya Yamamoto, Hirohito Naruse, Takanori Teshima
Clinicopathological features of primary splenic follicular lymphoma
Joji Shimono, Hiroaki Miyoshi, Tomohiko Kamimura, Tetsuya Eto, Takuto Miyagishima, Yuya Sasaki, Daisuke Kurita, Keisuke Kawamoto, Koji Nagafuji, Masao Seto, Takanori Teshima, Koichi Ohshima
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma
Beatrice Anna Zannetti, Paola Tacchetti, Lucia Pantani, Barbara Gamberi, Patrizia Tosi, Serena Rocchi, Claudia Cellini, Sonia Ronconi, Annalisa Pezzi, Katia Mancuso, Ilaria Rizzello, Isola Caratozzolo, Marina Martello, Luca Dozza, Michele Cavo, Elena Zamagni
High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma
Liang Wang, Jing-hua Wang, Wen-jian Liu, Wei-da Wang, Hua Wang, Xiao-qin Chen, Qi-rong Geng, Yue Lu, Zhong-jun Xia
At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment
Kai-ni Shen, Jun Feng, Xu-fei Huang, Chun-lan Zhang, Cong-li Zhang, Xin-xin Cao, Lu Zhang, Dao-bin Zhou, Jian Li
Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation
C. S. Michel, D. Teschner, E. M. Wagner, M. Theobald, Markus P. Radsak
VEGF, ANGPT1, ANGPT2, and MMP-9 expression in the autologous hematopoietic stem cell transplantation and its impact on the time to engraftment
Mateusz Nowicki, Agnieszka Wierzbowska, Roman Małachowski, Tadeusz Robak, Olga Grzybowska-Izydorczyk, Agnieszka Pluta, Anna Szmigielska-Kapłon
Clinical features of hematological disorders with increased large granular lymphocytes (LGLs): a retrospective study
Kensuke Matsuda, Kazuki Taoka, Masahiro Jona, Akiko Masuda, Shunya Arai, Fumihiko Nakamura, Yutaka Yatomi, Mineo Kurokawa
Interleukin-6 in idiopathic multicentric Castleman’s disease after long-term tocilizumab
Mitsuhiro Akiyama, Hidekata Yasuoka, Tsutomu Takeuchi
Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab
Bonnie Kho, Howard H. N. Wong, Chun-Fung Sin, Rock Y. Y. Leung, Yok-Lam Kwong
Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant
Bhagirathbhai Dholaria, Raj J. Patel, Jason C. Sluzevich, Sikander Ailawadhi, Vivek Roy
Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21)
Haigang Shao, Qian Yang, Chunxiao Wu, Jiannong Cen, Suning Chen, Jinlan Pan
Rare gene variants in a patient with azathioprine-induced lethal myelosuppression
Xiaoxue Yang, Heng Xu, Jun Yang, Li Yang
Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations
Prabhakar Kedar, Vaishali Parmar, Rati Devendra, Vinod Gupta, Prashant Warang, Manisha Madkaikar
Cytogenetic evidence for the clonal hematopoietic cell origin of alveolar macrophages in myelodysplastic syndrome-associated pulmonary alveolar proteinosis
Yuya Nagai, Chiyuki Kishimori, Miho Nakagawa, Ikkoh Yasuda, Gen Honjo, Hitoshi Ohno